Psyence Biomedical Ltd.

NASDAQ: PBM · Healthcare · Biotechnology

Canadian filerHQ Toronto, ONCIK 0001985062Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 21

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ filing timeliness, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

$1.0M

Employees

Market cap

$57.8k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income$1.0M$1.0M2025

Total assets$7.3M$7.3M2025

Liabilities$594.4k$594.4k2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Psyence Biomedical Ltd. earned $1.0M in FY2025 net income.

Peers · Healthcare

Allied Corp.——Endexx Corporation——Cannabis Global Inc.——Acura Pharmaceuticals, Inc.——

Key facts

CEOJody Aufrichtig

SectorHealthcare

IndustryBiotechnology

HeadquartersToronto, ON

ExchangeNASDAQ: PBM

Employees12

IPO date2021-12-10

Latest filings

20-F2026-06-22 6-K2026-06-05 6-K2026-04-23 6-K2026-04-20 6-K2026-04-17 6-K2026-04-15 6-K2026-03-02 6-K2026-02-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.